BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24479804)

  • 1. MicroRNAs in cancer: lessons from melanoma.
    Greenberg E; Nemlich Y; Markel G
    Curr Pharm Des; 2014; 20(33):5246-59. PubMed ID: 24479804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in the pathogenesis of malignant melanoma.
    Glud M; Gniadecki R
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):142-50. PubMed ID: 22621697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep sequencing analysis of microRNA expression in human melanocyte and melanoma cell lines.
    Ding N; Wang S; Yang Q; Li Y; Cheng H; Wang J; Wang D; Deng Y; Yang Y; Hu S; Zhao H; Fang X
    Gene; 2015 Nov; 572(1):135-145. PubMed ID: 26164755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.
    Aftab MN; Dinger ME; Perera RJ
    Arch Biochem Biophys; 2014 Dec; 563():60-70. PubMed ID: 25065585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cancer aggressive features in melanoma cells by microRNAs.
    Greenberg E; Hershkovitz L; Itzhaki O; Hajdu S; Nemlich Y; Ortenberg R; Gefen N; Edry L; Modai S; Keisari Y; Besser MJ; Schachter J; Shomron N; Markel G
    PLoS One; 2011 Apr; 6(4):e18936. PubMed ID: 21541354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.
    Wozniak M; Mielczarek A; Czyz M
    Curr Med Chem; 2016; 23(28):3136-3153. PubMed ID: 27666934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in melanoma biology.
    Kunz M
    Adv Exp Med Biol; 2013; 774():103-20. PubMed ID: 23377970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
    Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
    Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA heterogeneity in melanoma progression.
    Thyagarajan A; Tsai KY; Sahu RP
    Semin Cancer Biol; 2019 Dec; 59():208-220. PubMed ID: 31163254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
    Leibowitz-Amit R; Sidi Y; Avni D
    Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.
    Mueller DW; Rehli M; Bosserhoff AK
    J Invest Dermatol; 2009 Jul; 129(7):1740-51. PubMed ID: 19212343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells.
    Kozar I; Cesi G; Margue C; Philippidou D; Kreis S
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2980-2992. PubMed ID: 28408301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
    Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
    J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-sequencing data analyzing melanoma development and progression.
    Linck L; Liebig J; Völler D; Eichner N; Lehmann G; Meister G; Bosserhoff A
    Exp Mol Pathol; 2018 Dec; 105(3):371-379. PubMed ID: 30414979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.
    Segura MF; Greenwald HS; Hanniford D; Osman I; Hernando E
    Carcinogenesis; 2012 Oct; 33(10):1823-32. PubMed ID: 22693259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.
    Thyagarajan A; Shaban A; Sahu RP
    J Pharmacol Exp Ther; 2018 Jan; 364(1):1-12. PubMed ID: 29054858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.